Covid-19

News

FDA pulls AZ's Evusheld for COVID, citing lack of efficacy

AstraZeneca's revenue boost from COVID-19 therapy Evusheld looks set to be curbed early, as the FDA withdraws authorisation for the antibody on the grounds that it is ineffective against mo

News

US eyes link between Pfizer bivalent COVID jab and stroke

Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recomme

News

Falling demand sees J&J scale back COVID-19 vaccine

With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun

Market Access

Nine for 2023, part one: a reflection on inflection

The Roman god Janus, as we are frequently reminded in January, was two faced and able to look forward to the coming year and backward to reflect on the past one.

Sales & Marketing